← Leaderboards
Christopher Norfleet Kaufmann
University Of Florida
$3,356,428
Attributed
$3,356,428
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $761.7K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,356,428 · 4
By mechanism
R01$2,468,559 · 1
K01$655,803 · 1
K02$149,148 · 1
F31$82,918 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Yi Guo$3,756,653
- Hui Shao$4,879,138
- Caitrin W McDonough$1,019,914
- Tezcan Ozrazgat Baslanti$579,876
- Jingchuan Guo$1,978,842
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposImpaired CognitionElderlyCognitive PerformanceCognitiveFundingS Disease Related DementiaS Disease RiskCognitionS DiseaseHealth And Retirement StudyPreventionDementiaAgingLinkCognitive TestingCohort StudiesMedicare ClaimDiagnosisGuidelinesResearch PersonnelCareerPatternPharmaceutical Preparations
Grant awards (12)
Sleep apnea treatment and risk for cognitive decline and Alzheimers disease$609,341
R01 · FY2025 · AG · contact PI
Leadership Training in Real-World Data Analytics: Sleep and Alzheimer's Disease$149,148
K02 · FY2025 · AG · contact PI
Sleep apnea treatment and risk for cognitive decline and Alzheimers disease$612,626
R01 · FY2024 · AG · contact PI
Sleep apnea treatment and risk for cognitive decline and Alzheimers disease$612,626
R01 · FY2023 · AG · contact PI
Sedative-Hypnotic Use Patterns and Risk for Cognitive Decline and Alzheimer's Disease$127,710
K01 · FY2023 · AG · contact PI
Sleep apnea treatment and risk for cognitive decline and Alzheimers disease$633,966
R01 · FY2022 · AG · contact PI
Sedative-Hypnotic Use Patterns and Risk for Cognitive Decline and Alzheimer's Disease$127,710
K01 · FY2022 · AG · contact PI
Sedative-Hypnotic Use Patterns and Risk for Cognitive Decline and Alzheimer's Disease$134,103
K01 · FY2021 · AG · contact PI
Sedative-Hypnotic Use Patterns and Risk for Cognitive Decline and Alzheimer's Disease$133,461
K01 · FY2020 · AG · contact PI
Sedative-Hypnotic Use Patterns and Risk for Cognitive Decline and Alzheimer's Disease$132,819
K01 · FY2019 · AG · contact PI
Sedative-hypnotic use in US older adults: Recent trends and associated outcomes$40,686
F31 · FY2014 · AG · contact PI
Sedative-hypnotic use in US older adults: Recent trends and associated outcomes$42,232
F31 · FY2013 · AG · contact PI